Biological considerations of plasma-derived and recombinant factor VIII immunogenicity.

Lai, Jesse; Hough, Christine; Tarrant, Julie; Lillicrap, David

Lai, Jesse; Hough, Christine; Tarrant, Julie; Lillicrap, David.

Affiliation

Lai J; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Hough C; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Tarrant J; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Lillicrap D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.

Blood ; 129(24): 3147-3154, 2017 06 15.

Article in En | MEDLINE | ID: mdl-28432221

Subject(s)

Blood Coagulation Factor Inhibitors/immunology; Factor VIII; Hemophilia A; Plasma; Factor VIII/immunology; Factor VIII/therapeutic use; Hemophilia A/drug therapy; Hemophilia A/immunology; Humans; Recombinant Proteins/immunology; Recombinant Proteins/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma / Factor VIII / Blood Coagulation Factor Inhibitors / Hemophilia A Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google